Effects of Radial Extracorporeal Shock Wave and Kinesio Taping Treatments in Patients With Carpal… (NCT06850779) | Clinical Trial Compass
CompletedNot Applicable
Effects of Radial Extracorporeal Shock Wave and Kinesio Taping Treatments in Patients With Carpal Tunnel Syndrome
Turkey (Türkiye)76 participantsStarted 2023-10-01
Plain-language summary
Carpal Tunnel Syndrome (CTS) is a common upper extremity nerve compression syndrome that causes significant economic and social burden to affected individuals. Although the severity may vary among patients, symptoms such as night pain, transient numbness, tingling, constant pain, muscle weakness, and sleep disturbance may be observed. The treatment of CTS can be grouped as nonsurgical and surgical treatments. The aim of this study is to investigate the effects of treatment with sound waves and a healing method called extracorporeal shock wave therapy and a therapeutic flexible tape called kinesiology taping on pain, grip strength, quality of life, depression symptoms, hand functions, and ultrasonographic median nerve cross-sectional area in patients with CTS.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Mild to moderate unilateral carpal tunnel syndrome confirmed by electroneuromyography (ENMG)
* Patients over 18 years of age
* Symptom duration of at least 3 months
* Those who have not received any medical treatment other than analgesics in the last 3 months
Exclusion Criteria:
* Bilateral Carpal Tunnel Syndrome (CTS)
* Severe CTS detected by ENMG
* Operated CTS
* Corticosteroid injection within the last 3 months
* History of peripheral nerve damage
* Secondary CTS causes (thyroid dysfunction, connective tissue diseases)
* Cervical disc herniation
* DeQuervain tenosynovitis, trigger finger, Dupuytren contracture
* Inflammatory disorder
* Bleeding disorder
* Pregnancy
* Malignancy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain level before treatment, 3rd week and 6th week after treatment
Timeframe: From enrollment to the end of treatment at 3rd week and 6th week
2
Assessment of symptom severity and functionality
Timeframe: From enrollment to the end of treatment at 3rd week and 6th week
3
Assessment of median nerve cross sectional area by ultrasonography
Timeframe: From enrollment to the end of treatment at 3rd week and 6th week
Trial details
NCT IDNCT06850779
SponsorSisli Hamidiye Etfal Training and Research Hospital